Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

What's new in fibroblastic tumors?

Armstrong SM, Demicco EG.

Virchows Arch. 2019 Dec 11. doi: 10.1007/s00428-019-02682-x. [Epub ahead of print] Review.

PMID:
31828431
2.

Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23.

Kansara M, Thomson K, Pang P, Dutour A, Mirabello L, Acher F, Pin JP, Demicco EG, Yan J, Teng MWL, Smyth MJ, Thomas DM.

Cancer Discov. 2019 Nov;9(11):1511-1519. doi: 10.1158/2159-8290.CD-19-0154. Epub 2019 Sep 16.

PMID:
31527131
3.

Atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma in patients aged ≤ 40 years: a study of 116 patients.

Waters R, Horvai A, Greipp P, John I, Demicco EG, Dickson BC, Tanas MR, Larsen BT, Ud Din N, Creytens DH, Bahrami A, Doyle LA, Jo VY, Al-Ibraheemi A, Thway K, Jenkins SM, Siontis B, Folpe A, Fritchie K.

Histopathology. 2019 Dec;75(6):833-842. doi: 10.1111/his.13957. Epub 2019 Oct 13.

PMID:
31471922
4.

Detection of CSF1 rearrangements deleting the 3' UTR in tenosynovial giant cell tumors.

Ho J, Peters T, Dickson BC, Swanson D, Fernandez A, Frova-Seguin A, Valentin MA, Schramm U, Sultan M, Nielsen TO, Demicco EG.

Genes Chromosomes Cancer. 2020 Feb;59(2):96-105. doi: 10.1002/gcc.22807. Epub 2019 Sep 12.

PMID:
31469468
5.

The Immune Landscape of Cancer.

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS; Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I.

Immunity. 2019 Aug 20;51(2):411-412. doi: 10.1016/j.immuni.2019.08.004. No abstract available.

6.

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas.

Dancsok AR, Setsu N, Gao D, Blay JY, Thomas D, Maki RG, Nielsen TO, Demicco EG.

Mod Pathol. 2019 Dec;32(12):1772-1785. doi: 10.1038/s41379-019-0312-y. Epub 2019 Jul 1.

PMID:
31263176
7.

Comparison of published risk models for prediction of outcome in patients with extrameningeal solitary fibrous tumour.

Demicco EG, Griffin AM, Gladdy RA, Dickson BC, Ferguson PC, Swallow CJ, Wunder JS, Wang WL.

Histopathology. 2019 Nov;75(5):723-737. doi: 10.1111/his.13940. Epub 2019 Sep 5.

PMID:
31206727
8.

Cutaneous Syncytial Myoepithelioma Is Characterized by Recurrent EWSR1-PBX3 Fusions.

Jo VY, Antonescu CR, Dickson BC, Swanson D, Zhang L, Fletcher CDM, Demicco EG.

Am J Surg Pathol. 2019 Oct;43(10):1349-1354. doi: 10.1097/PAS.0000000000001286.

PMID:
31135487
9.

PRRX-NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm.

Lacambra MD, Weinreb I, Demicco EG, Chow C, Sung YS, Swanson D, To KF, Wong KC, Antonescu CR, Dickson BC.

Genes Chromosomes Cancer. 2019 Oct;58(10):705-712. doi: 10.1002/gcc.22762. Epub 2019 Apr 30.

PMID:
31008539
10.

Molecular updates in adipocytic neoplasms.

Demicco EG.

Semin Diagn Pathol. 2019 Mar;36(2):85-94. doi: 10.1053/j.semdp.2019.02.003. Epub 2019 Feb 28. Review.

PMID:
30857767
11.

A Contemporary Approach to Soft Tissue Tumors.

Demicco EG.

Surg Pathol Clin. 2019 Mar;12(1):ix. doi: 10.1016/j.path.2018.11.003. Epub 2018 Dec 20. No abstract available.

PMID:
30709450
12.

Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism.

Kim H, Yoo S, Zhou R, Xu A, Bernitz JM, Yuan Y, Gomes AM, Daniel MG, Su J, Demicco EG, Zhu J, Moore KA, Lee DF, Lemischka IR, Schaniel C.

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11128-E11137. doi: 10.1073/pnas.1814044115. Epub 2018 Nov 1.

13.

Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast.

Dickson BC, Hornick JL, Fletcher CDM, Demicco EG, Howarth DJ, Swanson D, Zhang L, Sung YS, Antonescu CR.

Genes Chromosomes Cancer. 2018 Sep;57(9):437-445. doi: 10.1002/gcc.22663. Epub 2018 Aug 14.

14.

TERT promoter mutations in solitary fibrous tumour.

Demicco EG, Wani K, Ingram D, Wagner M, Maki RG, Rizzo A, Meeker A, Lazar AJ, Wang WL.

Histopathology. 2018 Nov;73(5):843-851. doi: 10.1111/his.13703. Epub 2018 Sep 19.

PMID:
29985536
15.

The Immune Landscape of Cancer.

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS; Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I.

Immunity. 2018 Apr 17;48(4):812-830.e14. doi: 10.1016/j.immuni.2018.03.023. Epub 2018 Apr 5. Erratum in: Immunity. 2019 Aug 20;51(2):411-412.

16.

Optical imaging with a high-resolution microendoscope to identify sinonasal pathology.

Kidwai SM, Parasher AK, Schorn VJ, Demicco EG, Richards-Kortum R, Iloreta AM, Govindaraj S, Miles BA.

Am J Otolaryngol. 2018 Jul - Aug;39(4):383-387. doi: 10.1016/j.amjoto.2018.03.025. Epub 2018 Mar 20.

PMID:
29622347
17.

PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.

Cooper LA, Demicco EG, Saltz JH, Powell RT, Rao A, Lazar AJ.

J Pathol. 2018 Apr;244(5):512-524. doi: 10.1002/path.5028. Epub 2018 Feb 22. Review.

18.

USP6 activation in nodular fasciitis by promoter-swapping gene fusions.

Patel NR, Chrisinger JSA, Demicco EG, Sarabia SF, Reuther J, Kumar E, Oliveira AM, Billings SD, Bovée JVMG, Roy A, Lazar AJ, Lopez-Terrada DH, Wang WL.

Mod Pathol. 2017 Nov;30(11):1577-1588. doi: 10.1038/modpathol.2017.78. Epub 2017 Jul 28.

19.

Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model.

Demicco EG, Wagner MJ, Maki RG, Gupta V, Iofin I, Lazar AJ, Wang WL.

Mod Pathol. 2017 Oct;30(10):1433-1442. doi: 10.1038/modpathol.2017.54. Epub 2017 Jul 21.

20.

Preoperative vs postoperative radiation therapy in localized soft tissue sarcoma: Nationwide patterns of care and trends in utilization.

Lazarev S, McGee H, Moshier E, Ru M, Demicco EG, Gupta V.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):e507-e516. doi: 10.1016/j.prro.2017.04.010. Epub 2017 Apr 18.

21.

Reappraising hyalinizing clear cell carcinoma: A population-based study with molecular confirmation.

Hernandez-Prera JC, Kwan R, Tripodi J, Chiosea S, Cordon-Cardo C, Najfeld V, Demicco EG.

Head Neck. 2017 Mar;39(3):503-511. doi: 10.1002/hed.24637. Epub 2016 Nov 29.

PMID:
27898192
22.

Cutaneous nodular fasciitis with genetic analysis: a case series.

Kumar E, Patel NR, Demicco EG, Bovee JV, Olivera AM, Lopez-Terrada DH, Billings SD, Lazar AJ, Wang WL.

J Cutan Pathol. 2016 Dec;43(12):1143-1149. doi: 10.1111/cup.12828. Erratum in: J Cutan Pathol. 2017 May;44(5):512.

PMID:
27686647
23.

Racial disparities in incidence of human papillomavirus-associated oropharyngeal cancer in an urban population.

Ramer I, Varier I, Zhang D, Demicco EG, Posner MR, Misiukiewicz K, Genden EM, Miles BA, Teng MS, Sikora AG.

Cancer Epidemiol. 2016 Oct;44:91-95. doi: 10.1016/j.canep.2016.07.004. Epub 2016 Aug 9.

PMID:
27518158
24.

Adjuvant Therapy for Salivary Gland Carcinomas.

Sayan M, Vempati P, Miles B, Teng M, Genden E, Demicco EG, Misiukiewicz K, Posner M, Gupta V, Bakst RL.

Anticancer Res. 2016 Aug;36(8):4165-70.

PMID:
27466526
25.

Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.

Varier I, Keeley BR, Krupar R, Patsias A, Dong J, Gupta N, Parasher AK, Genden EM, Miles BA, Teng M, Bakst RL, Gupta V, Misiukiewicz KJ, Chiao EY, Scheurer ME, Laban S, Zhang D, Ye F, Cui M, Demicco EG, Posner MR, Sikora AG.

Head Neck. 2016 Sep;38(9):1330-7. doi: 10.1002/hed.24442. Epub 2016 Apr 15.

PMID:
27080140
26.

Clinical Outcomes in Patients with Recurrent or Metastatic Human Papilloma Virus-positive Head and Neck Cancer.

Dang RP, LE VH, Miles BA, Teng MS, Genden EM, Bakst RL, Gupta V, Zhang DY, Demicco EG, Posner MR, Misiukiewicz KJ.

Anticancer Res. 2016 Apr;36(4):1703-9.

PMID:
27069149
27.

Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma.

Roland CL, Boland GM, Demicco EG, Lusby K, Ingram D, May CD, Kivlin CM, Watson K, Al Sannaa GA, Wang WL, Ravi V, Pollock RE, Lev D, Cormier JN, Hunt KK, Feig BW, Lazar AJ, Torres KE.

JAMA Surg. 2016 Apr;151(4):347-54. doi: 10.1001/jamasurg.2015.4205.

28.

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas.

May CD, Garnett J, Ma X, Landers SM, Ingram DR, Demicco EG, Al Sannaa GA, Vu T, Han L, Zhang Y, Kivlin CM, Bolshakov S, Kalam AA, Liu J, Zhou F, Broccoli D, Wang WL, Lazar AJ, Pollock RE, Lev D, Torres KE.

BMC Cancer. 2015 Nov 14;15:901. doi: 10.1186/s12885-015-1916-3.

29.

Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas.

Chinyengetere F, Sekula DJ, Lu Y, Giustini AJ, Sanglikar A, Kawakami M, Ma T, Burkett SS, Eisenberg BL, Wells WA, Hoopes PJ, Demicco EG, Lazar AJ, Torres KE, Memoli V, Freemantle SJ, Dmitrovsky E.

BMC Cancer. 2015 Nov 10;15:886. doi: 10.1186/s12885-015-1883-8.

30.

Response to sunitinib of a gastrointestinal stromal tumor with a rare exon 12 PDGFRA mutation.

Brohl AS, Demicco EG, Mourtzikos K, Maki RG.

Clin Sarcoma Res. 2015 Sep 21;5:21. doi: 10.1186/s13569-015-0036-9. eCollection 2015.

31.

Soft Tissue Solitary Fibrous Tumor: Combined Surgery and Radiation Therapy Results in Excellent Local Control.

Bishop AJ, Zagars GK, Demicco EG, Wang WL, Feig BW, Guadagnolo BA.

Am J Clin Oncol. 2018 Jan;41(1):81-85. doi: 10.1097/COC.0000000000000218.

PMID:
26270446
32.

Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations.

Demicco EG, Wani K, Fox PS, Bassett RL, Young ED, Lev D, Aldape KD, Lazar AJ, Wang WL.

Hum Pathol. 2015 Jul;46(7):1015-26. doi: 10.1016/j.humpath.2015.03.014. Epub 2015 Apr 15.

PMID:
25976141
33.

Extensive survey of STAT6 expression in a large series of mesenchymal tumors.

Demicco EG, Harms PW, Patel RM, Smith SC, Ingram D, Torres K, Carskadon SL, Camelo-Piragua S, McHugh JB, Siddiqui J, Palanisamy N, Lucas DR, Lazar AJ, Wang WL.

Am J Clin Pathol. 2015 May;143(5):672-82. doi: 10.1309/AJCPN25NJTOUNPNF.

34.

Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma.

Ingram DR, Dillon LM, Lev DC, Lazar A, Demicco EG, Eisenberg BL, Miller TW.

BMC Clin Pathol. 2014 Oct 22;14:42. doi: 10.1186/1472-6890-14-42. eCollection 2014.

35.

Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.

Parikh F, Duluc D, Imai N, Clark A, Misiukiewicz K, Bonomi M, Gupta V, Patsias A, Parides M, Demicco EG, Zhang DY, Kim-Schulze S, Kao J, Gnjatic S, Oh S, Posner MR, Sikora AG.

Cancer Res. 2014 Dec 15;74(24):7205-16. doi: 10.1158/0008-5472.CAN-14-1913. Epub 2014 Oct 15.

36.

Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.

Demicco EG, Boland GM, Brewer Savannah KJ, Lusby K, Young ED, Ingram D, Watson KL, Bailey M, Guo X, Hornick JL, van de Rijn M, Wang WL, Torres KE, Lev D, Lazar AJ.

Histopathology. 2015 Apr;66(5):627-38. doi: 10.1111/his.12466. Epub 2015 Jan 12.

37.

Role of human papillomavirus and p16 staining in a patient with head and neck cancer presenting with a synchronous lung nodule: a case report and review of the literature.

Bonomi M, Abbott RW, Patsias A, Misiukiewicz K, Demicco EG, Zhang D, Kaufman A, Genden EM, Posner M.

J Clin Oncol. 2015 Jan 20;33(3):e13-5. doi: 10.1200/JCO.2013.50.0231. Epub 2014 Mar 3. Review. No abstract available.

PMID:
24590649
38.

Malignant peripheral nerve sheath tumors.

Farid M, Demicco EG, Garcia R, Ahn L, Merola PR, Cioffi A, Maki RG.

Oncologist. 2014 Feb;19(2):193-201. doi: 10.1634/theoncologist.2013-0328. Epub 2014 Jan 27. Review.

39.

Sarcoma diagnosis in the age of molecular pathology.

Demicco EG.

Adv Anat Pathol. 2013 Jul;20(4):264-74. doi: 10.1097/PAP.0b013e31829c2c7b. Review.

PMID:
23752088
40.

Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone.

Demicco EG, Wang WL, Madewell JE, Huang D, Bui MM, Bridge JA, Meis JM.

Am J Surg Pathol. 2013 May;37(5):752-62. doi: 10.1097/PAS.0b013e3182796e46.

PMID:
23588370
41.

Modeling Ewing sarcoma tumors in vitro with 3D scaffolds.

Fong EL, Lamhamedi-Cherradi SE, Burdett E, Ramamoorthy V, Lazar AJ, Kasper FK, Farach-Carson MC, Vishwamitra D, Demicco EG, Menegaz BA, Amin HM, Mikos AG, Ludwig JA.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6500-5. doi: 10.1073/pnas.1221403110. Epub 2013 Apr 1.

42.

Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.

Hoffman A, Ghadimi MP, Demicco EG, Creighton CJ, Torres K, Colombo C, Peng T, Lusby K, Ingram D, Hornick JL, Wang WL, Ravi V, Lazar AJ, Lev D, Pollock RE.

Cancer. 2013 May 15;119(10):1868-77. doi: 10.1002/cncr.27847. Epub 2013 Feb 7.

43.

Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.

Lusby K, Savannah KB, Demicco EG, Zhang Y, Ghadimi MP, Young ED, Colombo C, Lam R, Dogan TE, Hornick JL, Lazar AJ, Hunt KK, Anderson ML, Creighton CJ, Lev D, Pollock RE.

Ann Surg Oncol. 2013 Jul;20(7):2364-72. doi: 10.1245/s10434-012-2834-0. Epub 2013 Jan 20.

44.

INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma.

Yang J, Kantrow S, Sai J, Hawkins OE, Boothby M, Ayers GD, Young ED, Demicco EG, Lazar AJ, Lev D, Richmond A.

Cancer Res. 2012 Sep 15;72(18):4682-95. doi: 10.1158/0008-5472.CAN-12-0440. Epub 2012 Jul 26. Erratum in: Cancer Res. 2013 Aug 1;73(15):4962.

45.

Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma.

Brewer Savannah KJ, Demicco EG, Lusby K, Ghadimi MP, Belousov R, Young E, Zhang Y, Huang KL, Lazar AJ, Hunt KK, Pollock RE, Creighton CJ, Anderson ML, Lev D.

Clin Cancer Res. 2012 Sep 1;18(17):4633-45. doi: 10.1158/1078-0432.CCR-12-0436. Epub 2012 Jul 20.

46.

Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.

Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL.

Mod Pathol. 2012 Sep;25(9):1298-306. doi: 10.1038/modpathol.2012.83. Epub 2012 May 11.

47.

New therapeutic targets in soft tissue sarcoma.

Demicco EG, Maki RG, Lev DC, Lazar AJ.

Adv Anat Pathol. 2012 May;19(3):170-80. doi: 10.1097/PAP.0b013e318253462f. Review.

48.

Lymphocyte composition and distribution in inflammatory, well-differentiated retroperitoneal liposarcoma: clues to a potential adaptive immune response and therapeutic implications.

Tseng WW, Demicco EG, Lazar AJ, Lev DC, Pollock RE.

Am J Surg Pathol. 2012 Jun;36(6):941-4. doi: 10.1097/PAS.0b013e31824f2594. No abstract available.

PMID:
22446945
49.

Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors.

Ghadimi MP, Young ED, Belousov R, Zhang Y, Lopez G, Lusby K, Kivlin C, Demicco EG, Creighton CJ, Lazar AJ, Pollock RE, Lev D.

Clin Cancer Res. 2012 May 1;18(9):2545-57. doi: 10.1158/1078-0432.CCR-11-2592. Epub 2012 Mar 8.

50.

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.

Zhang P, Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL, Creighton CJ, Anderson ML, Lazar AJ, Calin GG, Pollock RE, Lev D.

Cancer Res. 2012 Apr 1;72(7):1751-62. doi: 10.1158/0008-5472.CAN-11-3027. Epub 2012 Feb 20.

Supplemental Content

Loading ...
Support Center